Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial

Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; this minor update does not alter study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:15:52.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The banner about a lapse in government funding and potential delays in updates has been removed. This notice was a general site operation message rather than content about the study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:59:28.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The STRONG study (NCT03381729) has been terminated early by the sponsor due to strategic objectives within the intrathecal SMA program. No further enrollment or dosing is planned.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:41.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Expanded topic coverage (Spinal muscular atrophy) and updated software version to v3.2.0, replacing the specific term Proximal spinal muscular atrophy and previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:32:12.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:35.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), indicating a new release. The Back to Top element was removed, which is a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T19:18:46.000Z thumbnail image

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.